12,932 Shares in Globe Life Inc. $GL Purchased by iSAM Funds UK Ltd

iSAM Funds UK Ltd bought a new position in Globe Life Inc. (NYSE:GL) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,932 shares of the company’s stock, valued at approximately $1,849,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Norges Bank purchased a new position in shares of Globe Life during the second quarter valued at approximately $157,722,000. AQR Capital Management LLC lifted its position in Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after purchasing an additional 696,548 shares during the period. Westfield Capital Management Co. LP bought a new position in Globe Life during the third quarter valued at approximately $61,569,000. Invesco Ltd. boosted its holdings in Globe Life by 3.9% in the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after purchasing an additional 147,644 shares during the last quarter. Finally, Candriam S.C.A. bought a new stake in Globe Life in the 2nd quarter worth approximately $17,997,000. Institutional investors own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on GL. Evercore set a $157.00 target price on shares of Globe Life in a research note on Wednesday, February 18th. Truist Financial raised their price target on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. JPMorgan Chase & Co. upped their price objective on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Wells Fargo & Company increased their target price on Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $171.33.

Insider Buying and Selling at Globe Life

In other news, CEO James Matthew Darden sold 18,318 shares of Globe Life stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the transaction, the chief executive officer directly owned 51,093 shares of the company’s stock, valued at $7,413,594.30. The trade was a 26.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the transaction, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 92,186 shares of company stock valued at $13,358,379 in the last ninety days. 1.51% of the stock is currently owned by company insiders.

Globe Life Stock Down 0.2%

Shares of GL stock opened at $138.51 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life Inc. has a 12 month low of $109.38 and a 12 month high of $152.71. The stock has a market cap of $10.89 billion, a P/E ratio of 9.84 and a beta of 0.46. The company has a 50 day simple moving average of $142.07 and a two-hundred day simple moving average of $139.01.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the business earned $3.14 EPS. The company’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, research analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.0%. This is a boost from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date is Thursday, April 2nd. Globe Life’s dividend payout ratio (DPR) is presently 7.67%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.